Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Pramanik D. Development of hedgehog pathway inhibitors (HPI) in treatment of cancer. Curr Chem Biol. 2014;8(3):132–48.
2. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8(10):743–54.
3. Wang C, Wu H, Katritch V, et al. Structure of the human smoothened receptor bound to an antitumour agent. Nature. 2013;497(7449):338–43.
4. Novartis. Odomzo® (sonidegib) capsules, for oral use: US prescribing information. 2015. http://www.accessdata.fda.gov/ . Accessed 27 July 2015.
5. Novartis. FDA approves Novartis drug Odomzo® (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer [media release]. 24 July 2015. https://www.novartis.com/news/news-archive .
Cited by
84 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献